Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses von Liu, W M, Fowler, D W, Smith, P, Dalgleish, A G

Volltext

Phase I Study of an Immunomodulatory Thalidomide Analog, CC-4047, in Relapsed or Refractory Multiple Myeloma von SCHEY, S. A, FIELDS, P, BARTLETT, J. B, CLARKE, I. A, ASHAN, G, KNIGHT, R. D, STREETLY, M, DALGLEISH, A. G

Volltext

Chronic immune activation and inflammation as the cause of malignancy von O'BYRNE, K. J, DALGLEISH, A. G

Volltext

Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells von Gravett, A. M., Stevanović, S., Dalgleish, A. G., Copier, J.

Volltext

Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells von Ioannou, N, Dalgleish, A G, Seddon, A M, Mackintosh, D, Guertler, U, Solca, F, Modjtahedi, H

Volltext

Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects von DREDGE, K, MARRIOTT, J. B, MACDONALD, C. D, MAN, H-W, CHEN, R, MULLER, G. W, STIRLING, D, DALGLEISH, A. G

Volltext

Phase I/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma von Green, D.S., Bodman-Smith, M.D., Dalgleish, A.G., Fischer, M.D.

Volltext

Improving the efficacy of cancer immunotherapy von Copier, J, Dalgleish, A.G, Britten, C.M, Finke, L.H, Gaudernack, G, Gnjatic, S, Kallen, K, Kiessling, R, Schuessler-Lenz, M, Singh, H, Talmadge, J, Zwierzina, H, Håkansson, L

Volltext

Review article: immune suppression and colorectal cancer von EVANS, C., DALGLEISH, A. G., KUMAR, D.

Volltext

Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs) von Liu, W M, Henry, J Y, Meyer, B, Bartlett, J B, Dalgleish, A G, Galustian, C

Volltext

Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced... von BARTLETT, J. B, MICHAE, A, ZELDIS, J, DALGLEISH, A. G, CLARKE, I. A, DREDGE, K, NICHOLSON, S, KRISTELEIT, H, POLYCHRONIS, A, PANDHA, H, MULLER, G. W, STIRLING, Dl

Volltext

Thalidomide and its analogues have distinct and opposing effects on TNF‐α and TNFR2 during co‐stimulation of both CD4+ and CD8+ T cells von MARRIOTT, J. B., CLARKE, I. A., DREDGE, K., MULLER, G., STIRLING, D., DALGLEISH, A. G.

Volltext

Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study von Lorigan, P., Marples, M., Harries, M., Wagstaff, J., Dalgleish, A.G., Osborne, R., Maraveyas, A., Nicholson, S., Davidson, N., Wang, Q., Pericleous, L., Bapat, U., Middleton, M.R.

Volltext

Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo von Henry, J.Y., Lu, L., Adams, M., Meyer, B., Bartlett, J.B., Dalgleish, A.G., Galustian, C.

Volltext

Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-γ and altered expression of Bcl-2 Bax von PETTERSSON, F, DALGLEISH, A. G, BISSONNETTE, R. P, COLSTON, K. W

Volltext

Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: Phase I clinical trial of three dosing schedules in patients with solid malignancies von Sharma, R.A., Steward, W.P., Daines, C.A., Knight, R.D., O’Byrne, K.J., Dalgleish, A.G.

Volltext

The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease von O'Byrne, K.J., Dalgleish, A.G., Browning, M.J., Steward, W.P., Harris, A.L.

Volltext

Supernatants derived from chemotherapy-treated cancer cell lines can modify angiogenesis von Liu, W M, Dennis, J L, Gravett, A M, Chanthirakumar, C, Kaminska, E, Coulton, G, Fowler, D W, Bodman-Smith, M, Dalgleish, A G

Volltext

Cancer vaccines as a therapeutic modality : the long trek von DALGLEISH, A. G, WHELAN, M. A

Volltext

Supernatants from lymphocytes stimulated with Bacillus Calmette-Guerin can modify the antigenicity of tumours and stimulate allogeneic T-cell responses von Liu, W M, Fowler, D W, Gravett, A M, Smith, P, Dalgleish, A G

Volltext